SHTLV-I/II seroprevalence in blood donors of Hospital Pablo Tobón Uribe Blood Bank during the period 2014-2015

Manuela Muñoz, Santiago Carvalho, Jorge Hernando Donado, Gloria Eugenia Barco, Sergio Jaramillo, .

Keywords: Human T-lymphotropic virus 1, human T-lymphotropic virus 2, blood donors, blood banks, prevalence, Retroviridae

Abstract

Introduction: The human-T cell lymphotropic virus is a retrovirus with various types known so far. HTLV-I and HTLV-II are of clinically importance as they cause different diseases such as adult T-cell leukemia/lymphoma, tropical spastic paraparesis, and human T-lymphotropic virus type I-associated myelopathy (HAM).
Objective: To estimate the prevalence of presumptive and confirmatory reactivity to HTLV-I/II in blood donors of Hospital Pablo Tobón Uribe Blood Bank between 2014 and 2015.
Materials and methods: The information was obtained from the Hospital Pablo Tobón Uribe Blood Bank database. We analyzed age, sex, place of origin, and place of residence of donors, and the reactivity using the screening test (ELISA) as well as the confirmatory test (immunoblot).
Results: The donor population studied included 6,275 men and 8,148 women, for a total of 14,423 donors recruited between March 1, 2014, and June 30, 2015. Of all tested donors, 25 were positive for HTLV-I/II by the screening test (ELISA). After performing the confirmatory test (immunoblot), only nine patients were positive for HTLV-I/II (36%), of whom eight were reactive to HTLV-I (32%) and one to HTLV-II (4%), for a global seroprevalence of 0.06% (CI 95%: 0.10-0.25).
Conclusions: Our findings were consistent with those found in similar studies in non-endemic areas of the country and with those from studies at international level reported in the literature.

Downloads

Download data is not yet available.
  • Manuela Muñoz Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia
  • Santiago Carvalho Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia
  • Jorge Hernando Donado Facultad de Medicina, Universidad Pontificia Bolivariana, Medellín, Colombia Unidad de Investigaciones y Docencia, Hospital Pablo Tobón Uribe, Medellín, Colombia
  • Gloria Eugenia Barco Banco de Sangre, Hospital Pablo Tobón Uribe, Medellín, Colombia
  • Sergio Jaramillo Departamento de Laboratorio Clínico y de Patología, Hospital Pablo Tobón Uribe, Medellín, Colombia

References

Paiva A, Casseb J. Sexual transmission of human T-cell lymphotropic virus type 1. Rev Soc Bras Med Trop. 2014;47:265-74. https://doi.org/10.1590/0037-8682-0232-2013

Xie J, Ge S, Zhang Y, Lin Y, Ni H, Zhang J, et al. The prevalence of human T-lymphotropic virus infection among blood donors in Southeast China, 2004-2013. PLoS Negl Trop Dis. 2015;9:e0003685. https://doi.org/10.1371/journal.pntd.0003685

Gonçalves DU, Proietti FA, Ribas JG, Araujo MG, Pinheiro SR, Guedes AC, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010;23:577-89. https://doi.org/10.1128/CMR.00063-09

Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24:6058-68. https://doi.org/10.1038/sj.onc.1208968

Murphy EL, Biswas HH. Human T-cell lymphotropic virus types I and II. En: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th edition. Philadelphia, PA: Churchill Livingstone/Elsevier; 2010. p. 2303-2322.

Cook LB, Elemans M, Rowan AG, Asquith B. HTLV-1: Persistence and pathogenesis. Virology. 2013;435:131-40. https://doi.org/10.1016/j.virol.2012.09.028

Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.https://doi.org/10.3389/fmicb.2012.00388

Vrielink H, Reesink HW. HTLV-I/II prevalence in different geographic locations. Transfus Med Rev. 2004;18:46-57. https://doi.org/10.1016/j.tmrv.2003.10.004

González-Arroyave JC. Infección por virus linfotrópico humano/de la leucemia de células T tipo I y II (HTLV-I y II). Espectro epidemiológico y clínico. Med UPB. 1999;18:47-58.

Ministerio de Salud y Protección Social. Resolución número 000437 de 2014. Fecha de consulta: 30 de noviembre de 2015. Disponible en: https://www.minsalud.gov.co/Normatividad_Nuevo/Resolución%200437%20de%202014.pdf

Quintana M, Villalobos J, Domínguez MC, Tamayo O, García-Vallejo F. Estudio de la seroprevalencia de la infección por los virus linfotrópicos humanos (HTLV) I y II en poblaciones del departamento de Córdoba, Colombia. Colombia Med. 2004;35:22-30.

Cortés-Buelvas A, Beltrán M, Gallego GA, Isaza LM. Estudio prospectivo seroepidemiológico de infección por el virus linfotrópico humano I y II (HTLV-I/II) en donantes de sangre de áreas colombianas endémicas y no endémicas. Colombia Med. 1999;30:19-25.

Martínez-Nieto O, Isaza-Ruget M, Rangel-Espinosa N, Morales-Reyes OL. Seroprevalencia de anticuerpos para virus linfotrópicos humanos (HTLV I/II) en donantes de sangre de una clínica de Bogotá, Colombia. 1999-2004. Rev Salud Pública. 2007;9:253-61. https://doi.org/10.1590/S0124-00642007000200009

Cruz-Bermúdez H, Collazos JE, Sierra MR, Fonseca AA. Seroprevalencia de tamizaje frente a virus linfotrópico de células T (HTLV) y factores asociados a coinfección en donantes voluntarios de sangre de Colombia. Salud Uninorte. 2014;30:95-103.

Biglione MM, Berini CA. Aportes y consideraciones sobre la infección por los virus linfotrópicos T humanos tipo 1 y 2 en Argentina. Rev Argent Salud Pública. 2013;4:32-7.

Macía C, Vargas S, Mora AM, Sarmiento AM, Pacheco R, Rosso F. Seroprevalencia del virus linfotrópico humano de tipos I y II en donantes del Banco de Sangre de la Fundación Valle del Lili, Cali, Colombia, 2008-2014. Biomédica. 2016;36:108-15. https://doi.org/10.7705/biomedica.v36i0.2942

Carrascal E, Cortés A, Akiba S, Tamayo O, Quiñones F, Flórez L, et al. Epidemiología y patología de la leucemia/linfoma de células T del adulto en Cali y el suroccidente colombiano. Colombia Med. 2004;35:12-7.

How to Cite
1.
Muñoz M, Carvalho S, Donado JH, Barco GE, Jaramillo S. SHTLV-I/II seroprevalence in blood donors of Hospital Pablo Tobón Uribe Blood Bank during the period 2014-2015. biomedica [Internet]. 2018 Mar. 15 [cited 2024 May 12];38(1):37-41. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/3417

Some similar items:

Published
2018-03-15
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code